SALT LAKE CITY–(BUSINESS WIRE)–Teiko, a CLIA clinical laboratory for monitoring the immune response, announced the publication of a review paper in Bioanalysis: https://doi.org/10.1080/17576180.2026.2744519. The paper, “Application of sample stabilization and mass cytometry in global oncology trials: lessons from regulatory T cell monitoring,” draws on the companies’ work in the first-in-human study of roginolisib, clinical precision oncology company iOnctura’s conformation-selective PI3K-delt
